» Articles » PMID: 22895583

A Simple Score for Estimating the Long-term Risk of Fracture in Patients with Multiple Sclerosis

Overview
Journal Neurology
Specialty Neurology
Date 2012 Aug 17
PMID 22895583
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To derive a simple score for estimating the long-term risk of osteoporotic and hip fracture in individual patients with MS.

Methods: Using the UK General Practice Research Database linked to the National Hospital Registry (1997-2008), we identified patients with incident MS (n = 5,494). They were matched 1:6 by year of birth, sex, and practice with patients without MS (control subjects). Cox proportional hazards models were used to calculate the long-term risk of osteoporotic and hip fracture. We fitted the regression model with general and specific risk factors, and the final Cox model was converted into integer risk scores.

Results: In comparison with the FRAX calculator, our risk score contains several new risk factors that have been linked with fracture, which include MS, use of antidepressants, use of anticonvulsants, history of falling, and history of fatigue. We estimated the 5- and 10-year risks of osteoporotic and hip fracture in relation to the risk score. The C-statistic was moderate (0.67) for the prediction of osteoporotic fracture and excellent (0.89) for the prediction of hip fracture.

Conclusion: This is the first clinical risk score for fracture risk estimation involving MS as a risk factor.

Citing Articles

Fatigue may improve equally after balance and endurance training in multiple sclerosis: a randomised, crossover clinical trial.

Perucca L, Scarano S, Russo G, Robecchi Majnardi A, Caronni A Front Neurol. 2024; 15:1274809.

PMID: 38385033 PMC: 10880192. DOI: 10.3389/fneur.2024.1274809.


Management of Osteoporosis, Fracture and Falls in People with Multiple Sclerosis: Systematic Review of Guidelines.

Grech L, Laurence K, Ebeling P, Sim M, Zengin A Calcif Tissue Int. 2023; 114(3):201-209.

PMID: 38015240 DOI: 10.1007/s00223-023-01159-z.


Multiple sclerosis is associated with low bone mineral density and osteoporosis.

Bisson E, Finlayson M, Ekuma O, Leslie W, Marrie R Neurol Clin Pract. 2019; 9(5):391-399.

PMID: 31750024 PMC: 6814427. DOI: 10.1212/CPJ.0000000000000669.


Risk Factors, Epidemiology and Treatment Strategies for Metabolic Bone Disease in Patients with Neurological Disease.

Binks S, Dobson R Curr Osteoporos Rep. 2016; 14(5):199-210.

PMID: 27525980 DOI: 10.1007/s11914-016-0320-5.


The Impact of the Choice of Data Source in Record Linkage Studies Estimating Mortality in Venous Thromboembolism.

Gallagher A, Williams T, Leufkens H, de Vries F PLoS One. 2016; 11(2):e0148349.

PMID: 26863417 PMC: 4749278. DOI: 10.1371/journal.pone.0148349.


References
1.
Schett G, David J . The multiple faces of autoimmune-mediated bone loss. Nat Rev Endocrinol. 2010; 6(12):698-706. DOI: 10.1038/nrendo.2010.190. View

2.
Ozgocmen S, Bulut S, Ilhan N, Gulkesen A, Ardicoglu O, Ozkan Y . Vitamin D deficiency and reduced bone mineral density in multiple sclerosis: effect of ambulatory status and functional capacity. J Bone Miner Metab. 2005; 23(4):309-13. DOI: 10.1007/s00774-005-0604-9. View

3.
Bazelier M, de Vries F, Bentzen J, Vestergaard P, Leufkens H, van Staa T . Incidence of fractures in patients with multiple sclerosis: the Danish National Health Registers. Mult Scler. 2011; 18(5):622-7. DOI: 10.1177/1352458511426739. View

4.
Wu Q, Liu J, Gallegos-Orozco J, Hentz J . Depression, fracture risk, and bone loss: a meta-analysis of cohort studies. Osteoporos Int. 2010; 21(10):1627-35. DOI: 10.1007/s00198-010-1181-x. View

5.
Dovio A, Perazzolo L, Osella G, Ventura M, Termine A, Milano E . Immediate fall of bone formation and transient increase of bone resorption in the course of high-dose, short-term glucocorticoid therapy in young patients with multiple sclerosis. J Clin Endocrinol Metab. 2004; 89(10):4923-8. DOI: 10.1210/jc.2004-0164. View